Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/33003
Title: | Susac Syndrome: Clinical characteristics, diagnostic findings and treatment in 19 cases |
Authors: | Karahan, S. Zengin Boz, C. Saip, S. Kale, N. Demirkaya, S. Celik, Y. Demir, S. Kurne, A. Terzi, M. Bursa Uludağ Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri/Nöroloji Bölümü. Ozbek, S. Erer 55325044500 |
Keywords: | Susac syndrome Corpus callosum Branch retinal artery occlusion Neurosciences & neurology |
Issue Date: | Aug-2019 |
Publisher: | Elsevier |
Citation: | Karahan, S. Z. vd. (2019). ''Susac Syndrome: Clinical characteristics, diagnostic findings and treatment in 19 cases''. Multiple sclerosis and relared disorders, 33, 94-99. |
Abstract: | Susac's Syndrome (SS), which was first described in 1979, is a rare and presumably autoimmune disorder characterized by encephalopathy, hearing loss, and visual disturbance resulting from branch retinal artery occlusion (BRAO). This study reports 19 SS patients' clinical characteristics, MRI features, CSF analysis, treatment strategies and outcomes. At initial presentation, only three of 19 patients demonstrated the complete clinical triad. Clinic presentation varied from isolated hemiparesis to the full triad (encephalopathy, hearing loss and visual disturbances). Corpus callosum (CC) involvement was noted in the MRI of 18 patients (97%) and BRAO was detected in 17 (95%) patients. All patients were treated with intravenous methylprednisolone after the initial assessment. This case series is presented to emphasize the differences in clinical presentation of SS and the importance of MRI and FFA in diagnosis. |
URI: | https://doi.org/10.1016/j.msard.2019.05.018 https://www.sciencedirect.com/science/article/pii/S2211034819302226 http://hdl.handle.net/11452/33003 |
ISSN: | 2211-0348 2211-0356 |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.